Book a Meeting

Anti-SLC34A2 Antibody, Highly Galactosylated (BioBet-GA-443ZP) (CAT#: BioBet-GA-443ZP) Datasheet

Target
SLC34A2
Isotype
IgG1, κ
Description
Anti-SLC34A2 Antibody, Highly Galactosylated (BioBet-GA-443ZP) is a human IgG1, κ antibody against SLC34A2 which contains with a high level of galactosylation.
Antibody Indication
Ovarian cancers
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced SLC34A2 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
SLC34A2
Full Name
Solute Carrier Family 34 Member 2
Background
The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. Phosphate uptake is increased at lower pH. Defects in this gene are a cause of pulmonary alveolar microlithiasis. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Alternative Names
SLC34A2; solute carrier family 34 (type II sodium/phosphate contransporter), member 2; NPTIIb; NAPI-3B; NAPI-IIb; sodium-dependent phosphate transport protein 2B; sodium/phosphate cotransporter 2B
Gene ID
10568
UniProt ID
O95436
Cellular Localization
Membrane
Genecards
11020
Involvement in Disease
Its related pathways are Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds and Mineral absorption.
Related Pathways
It may be involved in the transport of phosphate into cells via Na(+) cotransport. It may be the main phosphate transporter in the brush border membrane of the intestine. May be involved in the synthesis of surface active substances in the alveoli.
Field of research
1.Glycosylation at Asn295, Asn308, Asn313, Asn321, and Asn340 2.Modification sites at PhosphoSitePlus
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-GA-443ZP
Host
Human
Species Reactivity
Human
Description
The Highly Galactosylated Anti-SLC34A2 (Lifastuzumab), a biobetter antibody contains with a high level of galactosylation.
Antibody Indication
Ovarian cancers

Ovarian cancers

Related Products

Anti-SLC34A2 Antibody, Highly Galactosylated (BioBet-GA-444ZP) (CAT#: BioBet-GA-444ZP)
Anti-SLC34A2 Antibody, Half-Life Extended (AES-0622-ZP1309) (CAT#: AES-0622-ZP1309)
Anti-SLC34A2 Antibody, Non-Fucosylated (BioBet-443ZP) (CAT#: BioBet-443ZP)
Anti-SLC34A2 Antibody, Non-Fucosylated (BioBet-444ZP) (CAT#: BioBet-444ZP)
Anti-SLC34A2 Antibody, Recycling (AES-0622-ZP325) (CAT#: AES-0622-ZP325)
Anti-SLC34A2 Antibody, FcγRIIB Binding Enhanced (AES-0622-ZP653) (CAT#: AES-0622-ZP653)
Anti-SLC34A2 Antibody, On-Target (AES-0622-ZP981) (CAT#: AES-0622-ZP981)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.